Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models

BACKGROUND: Previous studies provide conflicting evidence on whether metformin is protective against cancer. When studying time-varying exposure to metformin, covariates such as body mass index (BMI) and glycated haemoglobin (HbA1c) may act as both confounders and causal pathway variables, and so ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Farmer, Ruth E, Ford, Deborah, Mathur, Rohini, Chaturvedi, Nish, Kaplan, Rick, Smeeth, Liam, Bhaskaran, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Risk Factors for Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469299/
https://www.ncbi.nlm.nih.gov/pubmed/30753459
http://dx.doi.org/10.1093/ije/dyz005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469299/
https://www.ncbi.nlm.nih.gov/pubmed/30753459
http://dx.doi.org/10.1093/ije/dyz005

Ejemplares similares